NSE / BSEHealthcare
β‚Ή5871.60+13.10+0.22%
P/E26.6Mkt Capβ‚Ή6.07 K CrEV/EBITDA17.2

Kovai Medical Center & Hospital Ltd

P/E26.6Mkt Capβ‚Ή6.07 K CrEV/EBITDA17.2
Company Profile

Kovai Medical Center and Hospital Limited operates a multi-speciality hospital primarily in India. The company operates in two segments, Healthcare Services and Education Services. It operates various medical facilities, which provide services related to emergency and trauma care, cardiology, oncology, gynaecology and obstetrics, radiology, transplant, neurology, as well as orthopaedics and joint replacement, gastroenterology and haematology, pediatrics, endocrinology, diabetes management, rheumatology, pulmonology, psychiatry, cosmetic surgery, ENT, dermatology, hematology, urology, nephrology, and paediatrics. The company also offers preventive health check-ups and wellbeing programs. In addition, it operates a medical college in Coimbatore. The company serves out-patients, in-patients, and common public. Kovai Medical Center and Hospital Limited was incorporated in 1985 and is based in Coimbatore, India.

Valuation

Market Cap
β‚Ή0.00
β€”
Current Price
β‚Ή0
β€”as of 28 Jul 2026
P/E Ratio
0.0x
β€”
P/B Ratio
0.0x
β€”
EV / EBITDA
0.0x
β€”
EV / Sales
0.0x
β€”
52W High
β‚Ή0
β€”
52W Low
β‚Ή0
β€”
Shares Out
0.00 Cr
β€”

Profitability

Operating Margin
0.0%
β€”
Net Profit Margin
0.0%
β€”
EBITDA Margin
0.0%
β€”

Returns

ROE
0.0%
β€”
ROCE
0.0%
β€”
ROIC %
β€”
β€”
ROA
0.0%
β€”
Dividend Payout
0.0%
β€”

Solvency

Current Ratio
0.0x
β€”
Debt / Equity
0.0x
β€”
Debt / Assets
0.0x
β€”
CFO / Net Profit
0.0x
β€”
Interest Coverage
0.0x
β€”

AI Summary

Indian Stock

Sign up free to view AI insights

Get Started

Rule-based from financial data. Not advice.

Price Historyβ–Ό 2.24% over 1Y
Monthly Returns

Historically, Aug has averaged the highest return (+8.8%); Mar the lowest (-2.9%).

Average from:
YearJanFebMarAprMayJunJulAugSepOctNovDec
2026-5.7%Negative MonthJan 2026: -5.65%-2.6%Negative MonthFeb 2026: -2.56%-5.0%Negative MonthMar 2026: -5.01%+12.8%Positive MonthApr 2026: +12.80%-5.4%Negative MonthMay 2026: -5.44%+12.0%Positive MonthJun 2026: +11.96%-2.1%*Negative MonthJul 2026: -2.11%β€”β€”β€”β€”β€”
2025-8.1%Negative MonthJan 2025: -8.14%-1.9%Neutral MonthFeb 2025: -1.93%-3.6%Negative MonthMar 2025: -3.63%+7.3%Positive MonthApr 2025: +7.34%+11.2%Positive MonthMay 2025: +11.19%-5.5%Negative MonthJun 2025: -5.48%+6.9%Positive MonthJul 2025: +6.90%+1.5%Neutral MonthAug 2025: +1.54%-3.3%Negative MonthSep 2025: -3.32%+4.3%Positive MonthOct 2025: +4.35%-6.3%Negative MonthNov 2025: -6.27%-4.1%Negative MonthDec 2025: -4.12%
2024+3.8%Positive MonthJan 2024: +3.83%+22.4%Positive MonthFeb 2024: +22.40%-5.0%Negative MonthMar 2024: -5.00%+11.8%Positive MonthApr 2024: +11.84%+0.3%Neutral MonthMay 2024: +0.27%+2.2%Positive MonthJun 2024: +2.20%+5.5%Positive MonthJul 2024: +5.46%+19.3%Positive MonthAug 2024: +19.30%-2.3%Negative MonthSep 2024: -2.30%+3.6%Positive MonthOct 2024: +3.57%-4.0%Negative MonthNov 2024: -4.03%+13.9%Positive MonthDec 2024: +13.90%
2023+3.6%Positive MonthJan 2023: +3.64%+9.8%Positive MonthFeb 2023: +9.78%-4.2%Negative MonthMar 2023: -4.18%+6.4%Positive MonthApr 2023: +6.45%+8.8%Positive MonthMay 2023: +8.76%+5.7%Positive MonthJun 2023: +5.65%+19.8%Positive MonthJul 2023: +19.75%-1.0%Neutral MonthAug 2023: -0.96%-2.7%Negative MonthSep 2023: -2.73%-2.0%Neutral MonthOct 2023: -1.96%+27.2%Positive MonthNov 2023: +27.18%-4.3%Negative MonthDec 2023: -4.31%
2022+3.2%Positive MonthJan 2022: +3.24%-12.1%Negative MonthFeb 2022: -12.15%+3.3%Positive MonthMar 2022: +3.29%+4.9%Positive MonthApr 2022: +4.90%-15.7%Negative MonthMay 2022: -15.74%+3.3%Positive MonthJun 2022: +3.32%+3.0%Positive MonthJul 2022: +3.05%-0.7%Neutral MonthAug 2022: -0.70%+1.4%Neutral MonthSep 2022: +1.42%-1.1%Neutral MonthOct 2022: -1.08%+18.2%Positive MonthNov 2022: +18.22%-4.5%Negative MonthDec 2022: -4.52%
2021β€”β€”β€”β€”β€”+2.6%Positive MonthJun 2021: +2.65%+3.0%Positive MonthJul 2021: +2.98%+24.8%Positive MonthAug 2021: +24.77%-3.5%Negative MonthSep 2021: -3.52%-1.1%Neutral MonthOct 2021: -1.05%-0.7%Neutral MonthNov 2021: -0.74%+2.6%Positive MonthDec 2021: +2.57%
AvgΒ±SD-0.6%Β±5.2%+3.1%Β±11.9%-2.9%Β±3.1%+8.7%Β±3.1%-0.2%Β±9.8%+3.4%Β±5.2%+6.0%Β±6.8%+8.8%Β±11.0%-2.1%Β±1.8%+0.8%Β±2.6%+6.9%Β±13.3%+0.7%Β±7.1%
* Current month β€” value will change until month-end.

Each cell is the percentage change in closing price from the end of the prior month to the end of this month. The bottom row shows the average return for that calendar month across the selected years, plus or minus one standard deviation β€” the range that historically contained roughly two-thirds of outcomes. Past monthly patterns are not a forecast of future returns.

Seasonal Tendency

This aggregates every month by calendar position β€” all Januaries together, all Februaries together, and so on β€” to show whether a given month has leaned positive or negative historically. β€˜Simple’ counts each month as +1 or βˆ’1. β€˜Weighted’ gives larger moves more influence: +2 above +10%, βˆ’2 below βˆ’10%. With only 6 years of history for this asset, each month’s score reflects a small number of observations β€” read it as a historical tendency, not a reliable seasonal pattern.

Historical Trend

This tracks a running tally across the asset’s full price history: each month adds or subtracts based on whether it was positive or negative. A rising line means more positive months than negative so far; a flattening or falling line means recent months have leaned negative. This measures historical month-to-month consistency, not expected future performance.

Year-to-Date ROI
Average from:
SD Γ—
Latest: 1.021x (2026)

Year-to-date return is calculated by dividing each day’s closing price by the price on January 1st of that year (or the asset’s first available price if it began trading mid-year). The custom average line shows the mean YTD return at each calendar day across the selected years. The standard deviation band shows the range within which returns have historically fallen β€” at 1 SD, roughly two-thirds of years; at 2 SD, roughly 95%. Past year-to-date patterns do not predict future returns. The average and standard deviation band are computed from the year set chosen in β€œAverage from”, which is independent of which year lines are displayed. The current in-progress year is excluded from these calculations, since a partial year is not comparable to complete ones. Election-cycle groupings follow the US presidential calendar and are offered only for US and crypto assets.

Historical Performance

Revenue, profitability, and cash flow trends (β‚Ή Crores)

Revenue (10Y)

Operating Income (10Y)

Net Profit (10Y)

Operating Margin % (10Y)

Dividend Payout % (10Y)

Free Cash Flow (10Y)

Growth Summary

Latest fiscal year: Mar 2025

Revenueβ‚Ή1.37 K Crβ–² 12.4%
EBITDA Growthβ€”
Net Profitβ‚Ή209.00 Crβ–² 16.1%
Cash from Ops (CFO)β€”
Free Cash Flow (FCF)β€”β–² 4.2%
Revenue CAGR 5Y11.4%
EBITDA CAGR 5Y15.2%
Net Profit CAGR 5Y13.6%
NP Growth 1Y16.1%

Historical Growth

Year-by-year revenue, profitability, and cash flow (β‚Ή Crores, last 10 years)

YearRevenueOp. IncomeNet ProfitCFOFCFROERev Growth 1YNP Growth 1Y
Mar 2025β‚Ή1.37 K Crβ€”β‚Ή209.00 Crβ€”β€”19.2%12.4%16.1%
Mar 2024β‚Ή1.22 K Crβ€”β‚Ή180.00 Crβ€”β€”20.2%19.6%55.2%
Mar 2023β‚Ή1.02 K Crβ€”β‚Ή116.00 Crβ€”β€”16.1%12.7%11.5%
Mar 2022β‚Ή905.00 Crβ€”β‚Ή104.00 Crβ€”β€”17.1%31.2%33.3%
Mar 2021β‚Ή690.00 Crβ€”β‚Ή78.00 Crβ€”β€”15.3%-3.1%-17.9%
Mar 2020β‚Ή712.00 Crβ€”β‚Ή95.00 Crβ€”β€”22.0%13.4%58.3%
Mar 2019β‚Ή628.00 Crβ€”β‚Ή60.00 Crβ€”β€”17.5%6.8%3.4%
Mar 2018β‚Ή588.00 Crβ€”β‚Ή58.00 Crβ€”β€”20.2%10.7%-3.3%
Mar 2017β‚Ή531.00 Crβ€”β‚Ή60.00 Crβ€”β€”25.5%14.2%50.0%
Mar 2016β‚Ή465.00 Crβ€”β‚Ή40.00 Crβ€”β€”22.7%15.7%2.6%

Financial Statements

Income statement, balance sheet, and cash flow (β‚Ή Crores, as reported)

Consolidated Figures in USD Millions.

Unnamed: 0Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue / Net Sales3344024655315886287126909051,0201,2201,3711,478
Total Expenses2613073744064594945404956457468749811,061
EBIT / Operating Profit739492125129135171195261274346390417
OPM %22%23%20%23%22%21%24%28%29%27%28%28%28%
Other Income57867810121214212125
Finance Costs24201715131518334643373636
Depreciation & Amortisation162121243436526885899298102
Profit Before Tax375962928993112106141155238278304
Tax %36%35%35%35%35%35%15%27%26%25%24%25%-
Net Profit / PAT2439406058609578104116180209229
EPS (β‚Ή)21.6835.3736.9554.8152.9954.9686.447195.28105.80164.25190.96208.90
Dividend Payout %7%4%7%5%6%5%3%4%6%9%6%5%-

Peer Comparison

Healthcare sector peers, ranked by market cap

CompanyMarket CapRevenueP/EP/BEV/EBITDARev G 1Y
Kovai Medical Center & Hospital Ltdthis co.β‚Ή6.07 K Crβ‚Ή1.37 K Cr26.605.1017.2312.4%
Sun Pharmaceutical Industries Ltd.β‚Ή4.15 L Crβ‚Ή23.00 K Cr88.7017.4372.3013.5%
Divi's Laboratories Ltd.β‚Ή1.71 L Crβ‚Ή9.20 K Cr67.9011.1367.2120.0%
Torrent Pharmaceuticals Ltd.β‚Ή1.33 L Crβ‚Ή9.68 K Cr62.5015.7645.6413.5%
Cipla Ltd.β‚Ή1.17 L Crβ‚Ή19.05 K Cr22.503.5119.3314.9%
Apollo Hospitals Enterprises Ltd.β‚Ή1.05 L Crβ‚Ή8.20 K Cr75.0011.2854.4412.8%
Max Healthcare Institute Limitedβ‚Ή1.00 L Crβ‚Ή2.66 K Cr144.0011.7696.8413.8%
Industry Averageβ€”β‚Ή3.29 K Cr98.638.1165.5020.2%

Learn while you research

Hand-picked academy chapters to deepen your understanding of Kovai Medical Center & Hospital Ltd and the metrics that matter.

Browse the full Equiscale Academy